Genomics

Dataset Information

0

Genomic and transcriptomic analysis of baseline PDAC patients' tumors from the OXIRI phase 1b clinical trial


ABSTRACT: This study was aimed at investigating the genomic and transcriptomic features associated with response to the OXIRI regimen (oxaliplatin, irinotecan, capecitabine) in pancreatic ductal adenocarcinoma (PDAC) tumors. We performed whole-exome sequencing (WES) and RNA sequencing (RNA-seq) on baseline tumor samples obtained from 8 patients recruited in the OXIRI phase 1b clinical trial (NCT02368860).

PROVIDER: EGAS00001006073 | EGA |

REPOSITORIES: EGA

Similar Datasets

2023-09-11 | GSE217845 | GEO
2023-09-11 | GSE217846 | GEO
2023-09-11 | GSE237846 | GEO
2023-09-11 | GSE217843 | GEO
2024-08-26 | GSE275628 | GEO
| PRJNA556657 | ENA
2015-01-20 | E-GEOD-52812 | biostudies-arrayexpress
| PRJNA764032 | ENA
2020-04-27 | GSE149126 | GEO
2014-07-08 | E-GEOD-49149 | biostudies-arrayexpress